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ABSTRACT 
Objective: To characterize the oral mucositis in patients under oncological treatment. Method: This is a descriptive 
and exploratory study with a quantitative approach, which was performed with 50 patients in a philanthropic hospital 
in the city of Teresina/PI/Brazil, from August to October 2010. Results: The outcomes showed the prevalence of oral 
mucositis in males and in the age groups lesser than 17 and over 60 years. The most frequent oncological diagnoses 
were leukemias and aerodigestive route cancers, whose treatments were focused on chemoradiotherapy, by 
predominantly determining the grades 1 and 2 of oral mucositis. The most associated chemotherapic agents with the 
disease were: cisplatin, cytarabine, methotrexate, vincristine sulfate, etoposide, doxorubicin hydrochloride. 
Conclusion: It is concluded that there is a need of including the nursing in fostering the preventive and controlling 
actions towards the oral mucositis, in order to maintain the welfare, therapeutic response optimization and 
improvement of the life quality of the oncological patient. Descriptors: Oral mucositis, Oncology, Nursing. 
 
RESUMO 
Objetivo: Caracterizar a mucosite oral em pacientes em tratamento oncológico. Método: Estudo exploratório-
descritivo com abordagem quantitativa, o qual foi realizado com 50 pacientes em um hospital filantrópico em 
Teresina/PI, de agosto a outubro de 2010. Resultados: Os achados apontaram a prevalência de mucosite oral no gênero 
masculino e nas faixas etárias inferiores a 17 e superiores a 60 anos. Os diagnósticos oncológicos mais freqüentes foram 
as leucemias e os cânceres das vias aerodigestivas superiores, cujos tratamentos se concentravam na quimiorradiação, 
determinando predominantemente graus 1 e 2 de mucosite oral. Os quimioterápicos mais associados à afecção foram: 
cisplatina, citarabina, metotrexate, sulfato de vincristina, etoposídeo, cloridrato de doxorrubicina. Conclusão: 
Conclui-se que há necessidade da inserção da enfermagem no fomento às ações preventivas e de controle da mucosite 
oral, com vistas à manutenção do bem-estar, otimização da resposta terapêutica e melhoria da qualidade de vida do 
paciente oncológico. Descritores: Mucosite oral, Oncologia, Enfermagem. 
 
RESUMEN 
Objetivo: Caracterizar la estomatitis en pacientes en tratamiento contra el cáncer. Método: Estudio descriptivo, 
exploratorio, cuantitativo, con 50 pacientes en hospital de caridad de Teresina-PI, Brasil, de agosto a octubre de 2010. 
Resultados: Los hallazgos señalaron prevalencia de la estomatitis en hombres y en los grupos de edad inferiores a 17 y 
mayores de 60 años. Los diagnósticos de cáncer fueron las leucemias y los cánceres más frecuentes del tracto digestivo 
superior, cuyos tratamientos se centraron en la quimiorradioterapia, determinando principalmente grado 1 y 2 de la 
estomatitis. Los quimioterapéuticos más asociados con la enfermedad fueron: cisplatino, citarabina, metotrexato, 
sulfato de vincristina, etopósido y doxorubicina clorhidrato. Conclusión: hay necesidad de inclusión de la enfermería 
en la promoción de acciones para controlar y prevenir la estomatitis para el mantenimiento del bienestar, optimización 
de la respuesta terapéutica y mejora de la calidad de vida de pacientes con cáncer. Descriptores: Estomatitis, 
Oncología, Enfermería. 
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To know the reality of patients under 
oncological treatment is something instigating, 
because of the numerous deleterious aspects that 
cancer assumes in the life of the affected subject, 
which range from the diagnostic discovery until 
the confrontation of the antineoplastic therapy. 
This might determine the toxic effects in a short 
or long term, which greatly alter the life quality 
of the individual living with cancer. Among the 
complications of the short term treatment, it 
should be highlighted the oral mucositis.  
This is a toxic and inflammatory reaction 
that affects the entire gastrointestinal tract, and 
is a sequel to the cytoreductive treatment induced 
by radiotherapy and / or chemotherapy in patients 
subjected to bone marrow transplantation. 1 Its 
origin is multifactorial and might be genetically 
determined, but its occurrence and severity are 
mainly associated with the antineoplastic 
treatment according to chemotherapy frequency 
and administration, radiation intensity and 
treatment duration. Other patient-related factors 
such as age, gender, leukocyte counting, 
nutritional status and oral hygiene also compose 
the mucositis casuistry.2 
To characterize such a disease, the World 
Health Organization (WHO) proposed, in 1979, the 
Oral Mucositis Graduation Scale, which takes into 
account the anatomical, functional and 
symptomatic mucositis aspects, classifying it into 
grades 0, 1, 2 3 and 4, from the absence of 
injuries until the impossibility of feeding by the 
patient, being that the grade 4 is the highest 
commitment level. Thus, one has a tool to stratify 
the patients and guide the best conducts.1 
Nursing should be inserted in this issue, by 
giving importance to the early recognition of 
changes in the oral mucosa in patients subjected 
to oncological treatments; assessment tools; 
establishment of nursing intervention protocols; 
patient and family education; care and oral 
hygiene programs; multidimensional understanding 
of pain and its management; main agents for 
prevention and treatment recommended in the 
literature for oral mucositis and the assessment 
regarding their usage and/or recommendation by 
the nursing professional.3 Nonetheless, so that we 
can operate efficiently and effectively, it is 
necessary, first of all, to take ownership of the 
issue. Thus, this work is justified by the relevance 
and impact of the oral mucositis condition in the 
daily lives of most oncological patients, by 
directly influencing in their prognostics.  
Hence, this study aimed to clinically characterize 
the oral mucositis, by correlating it with 
implemented therapeutic and searching for an 
interface with the nursing care. 
 
 
This is an exploratory study with a 
quantitative approach, whose scenario was the 
oncological clinic of a philanthropic hospital from 
the city of Teresina/PI/Brazil, which is comprised 
of three nursing stations, totaling 80 hospital beds 
with exclusive attendance by the Brazilian Unified 
Health System (known as SUS). The population was 
composed of oncological patients admitted to the 
clinic who presented oral mucositis, by forming a 
sample of 50 patients, adults and children, 
obtained by non-probabilistic sampling through 
accessibility.  
For including the participants, we have 
considered the following criteria: to show a cancer 
diagnostic; to be in antineoplastic treatment or 
post-treatment, radiotherapy and/or 
chemotherapy and to be admitted to the 
oncological clinic at stake.   
Data collection was performed from 
September to October 2010 with approach to the 
patients through application of a structured form 
and accomplishment of a physical examination of 
the oral mucosa, for submission in the Oral 
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Mucositis Graduation Scale, proposed by the WHO, 
by signing the Free and Informed Consent Form, 
by subject or guardian, and other requirements of 
the Resolution 196/964, as approval by the Ethics 
Research Committee from the Federal University 
of Piauí, under CAAE nº 0207.0.045.000-10. 
The obtained data were subjected to 
descriptive analysis by means of the software 
Statistical Package for Social Sciences - SPSS 
(version 17.0) and discussed on the basis of the 
specialized literature. 
 
 
  
  
 The obtained data, after approaching the 
50 subjects participating in the study, are 
presented in the following tables. 
 
Table 1. Sociodemographic profile of patients with 
oral mucositis (n=50). Teresina/PI, 2010. 
 
Men were expressly the worst affected 
(70%) by oral mucositis and the age groups that 
have showed higher recurrence of the disease 
encompassed people from 1 to 17 years (38%) and 
aged over 60 (32%). The low schooling level has 
prevailed in study subjects, with a percentage of 
54% regarding the Elementary School. With regard 
to the family income, it was observed that most 
were not employed (64%). 
  
Table 2. Characterization of patients with oral 
mucositis regarding the cancer type and the 
implemented oncological treatment (n=50). 
Teresina/PI, 2010. 
 
Caption: ALL: Acute Lymphoblastic Leukaemia; AML: Acute 
Myeloid Leukemia.*Oropharynx and larynx. **Bone cancer, 
gastric, Wilms’ tumor, Burkit and Hogdkin lymphomas. 
 
Regarding the pathological profile of 
patients with oral mucositis, 20 types of 
neoplasms were detected in the 50 surveyed 
subjects. Aerodigestive, oropharynx and larynx 
cancers (28%), followed by Acute Lymphoblastic 
Leukemia (ALL) (20%) represented the most 
incident neoplasms. Head and neck cancers were 
the common diagnoses in 14% of patients. The 
Acute Myeloid Leukemia (AML) configured a 
percentage of 10% of subjects and of mouth and 
tongue cancers of, 8% of the total. Unspecified 
acute leukemia has reached a sample of 6%. 
Other cancers types, such as bone and gastric 
neoplasms, Wilms' tumor, Burkit and Hogdkin 
lymphomas, represented the diagnoses present in 
14% of patients with mucositis. 
Table 3. Ratio between the grade and type of oral 
mucositis and the oncological treatment type 
(n=50). Teresina/PI, 2010. 
 
Of 50 surveyed patients, 50% 
concomitantly performed chemotherapy and 
radiotherapy as oncological treatments, 44% 
RESULTS AND DISCUSSION 
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underwent only chemotherapy and the others 6% 
only radiotherapy. The oral mucositis type 
manifested in these subjects was more incident 
in the following grades, respectively: grade 1 
(44%), grade 2 (36%), grade 3 (14%) and grade 4 
(6%). It is noteworthy to note that the mucositis 
grade 4, greater impairment of the integrity of 
the oral mucosa, manifested itself only in 
patients under chemoradiotherapy. The 
remaining mucositis grades were noted in the 
three therapeutic modalities, except grade 3, 
which was not observed in patients under 
radiotherapy. 
 
Table 4. Ratio between the oral mucositis grade 
and the chemotherapic drugs used by patients 
(n=50). Teresina/PI, 2010. 
 
Caption: *Mercaptopurine, ifosfamide, allopurinol, 
daunorubicin, carboplatin, oxilaplatin and carmustatine. 
**Absolute frequency higher than n=45, since in the sample 
had patients who make use of more than one chemotherapic 
drug. 
 
The total number of surveyed patients 
regarding the use of chemotherapic drugs was 45, 
and not the total amount of 50. That is why three 
patients underwent only radiotherapy treatment 
and two were in post-chemotherapic treatment. 
The large majority of patients made use of more 
than one chemotherapic drug; hence, the total 
absolute frequency extends beyond the sample of 
45. 
 Cisplatin was the most incident 
chemotherapic drug in the prescriptions of 
surveyed patients, for a total of 44.4%, followed 
by cytarabine (31.1%), methotrexate (28.9%), 
vincristine sulfate (13.3%) and doxorubicin 
hydrochloride and etoposide (11.1%), each one. 
 
Table 5. Ratio between the oral mucositis grade 
and its interference in the oncological treatment 
(n=50).Teresina/PI, 2010. 
 
When we assessed the interference of oral 
mucositis in the oncological treatment, it might 
be inferred that, in 82% of patients, mucositis 
was not preponderant factor for therapeutic 
disruption, compared with 18% of patients who 
had their oncological treatments delayed for the 
purposes of primary treatment of oral mucositis. 
In the latter case, 66.7% were bearers of oral 
mucositis in grade 4, while a small portion of 
9.1% had mucositis in its first grade. 
 
When analyzing the sociodemographic 
profile of the screened subjects, we have found 
that mucositis was more incident in men, 
although statistics confirm that women are more 
affected in a general way by cancer in Brazil, by 
composing a scenario of 3.340 cancer cases 
before 2.830 cases in men for the year 2012. 5 
Nevertheless, the same statistical data (5) point 
out, in relation to the studied Brazilian State, the 
prevalence of aerodigestive route cancers in 
males, due to habits of alcoholics and smokers, 
mainly. Such a reality makes closer the ratio 
between gender and oral mucositis, since in cases 
of these cancer types of the aerodigestive routes, 
the treatments provide greater exposure and 
deterioration of the gastrointestinal tract 
mucosa, by determining a greater amount of 
mucositis cases.  
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Concerning the age group, there were 
children, teenagers and elderly as the most 
affected subjects by the disease at stake. As 
confirmed in the literature, children and 
teenagers are the most often victims of 
mucositis, because of the high proliferation of 
the basal mucosa and resistance variation. 6 
Furthermore, the prevailing cancer types in 
children are the hematological ones, such as 
leukemias and lymphomas, which together cause 
bone marrow suppression and, therefore, tend to 
be associated to the oral complications with high 
frequency. Regarding the elderly, these are also 
common victims of mucositis, especially by the 
weakness of their immunological system and for 
composing the age group in which the cancer is 
more prevalent.5 Thus, these individuals due to 
being more susceptible to carcinogenesis, are 
also more vulnerable to the deleterious effects 
arising from the oncological treatments, such as 
oral diseases.  
Most subjects were not employed, so we 
should denote that, excluding the child audience, 
economically inactive, the financial situation of 
the patients seems limited, which hinders the 
funding of resources for the treatment and its 
complications. Moreover, the schooling level was 
poor, with the majority of the sample holding 
only the Elementary School. Low levels of income 
and schooling are variables that interfere with 
the adherence to preventive and therapeutic 
behaviors by the patients. The usage of 
permanent education techniques, which adopt 
alternative parlances for the target audience, 
becomes crucial to make the patient an active 
subject in its healing process. As an example, the 
approach to children through therapeutic toys 
and permanent health education, which makes 
use of an accessible and understandable parlance 
to all social classes; thus, it is essential to involve 
the individual in this educational process, by 
considering its knowledge about the health-
disease process and linking it to its world 
viewpoint, values, attitudes and beliefs of 
society.8  
When ascertaining the clinical aspect of 
the subjects, it should be emphasized a high 
incidence of leukemia, especially ALL, in the 
presented data, which can be explained by the 
amount of children covered in this study, since 
leukemia is the most common neoplasm in the 
childhood stage, by predominantly occurring in 
the age group from 0 to 14 years, being that it is 
rare in adults. The ALL corresponds to 85% of all 
leukemias, by reaching 1/25.000 individuals a 
year. 9 The chemotherapic treatment might result 
in multiple complications, including anemia, 
infections and oral mucositis. Because of the 
bone marrow immune-suppression caused by 
leukemia, the affected patients develop 
oral/dental problems two to three times more 
often than patients with solid tumors.10 
 The numbers were significant in relation 
to the aerodigestive route, head and neck, mouth 
and tongue cancers. This occurs because of the 
neoplasms that affect the upper respiratory and 
digestive tracts, the high rate of cellular renewal 
and the low radiotherapy resistance of epithelial 
cells of these areas, which early answer to the 
toxic effects of radiation and of chemotherapic 
drugs to which they are exposed.11 These cancer 
types have in common the treatment based on 
radiotherapy, with field action in the head and 
neck, which clearly exposes the oral mucosa. 
Patients irradiated in the head and neck regions 
usually suffer oral and tasting changes, due to 
the xerostomy and dysphagia, which directly 
interferes with their daily activities.12 
By considering the patients with the same 
mucositis grade, this manifests itself, mainly, 
when there is a combination of radiotherapy and 
chemotherapy during the oncological treatment. 
A similar study13 shows that the occurrence of 
oral mucositis ranges from 40 to 60% of patients 
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subjected to chemotherapy. In patients under 
conditioning for bone marrow transplantation, 
such a value can reach a rate of 75%; in the head 
and neck radiotherapy treatment, the percentage 
is around 50% and, when the chemotherapic 
treatment is associated to radiotherapy, such a 
value reach 90% of occurrence.  
Radiotherapy combined with 
chemotherapy for cancer treatment is potentially 
toxic to the oral mucosa cells, by hindering 
swallowing, by limiting speech and chewing, 
besides exposing the patient to the infections 
caused by opportunistic microorganisms, resulting 
in a decreased life quality. 14-12 However, even 
with too many adverse effects, 
chemoradiotherapy is the most accepted 
procedure by experts, not only because it enables 
the tumoral volume reduction, but also due to 
increasing the blood supply and oxygen 
contribution, by making the patients more 
susceptible to other oncological treatments. 
Thus, in view of the cost-benefit ratio, 
chemoradiotherapy is chosen as the better 
treatment for most neoplasm cases, in spite of its 
secondary side effects.15   
Regarding the mucositis grades, it is 
important to notice that their assessment takes 
place from signs and symptoms reported by the 
oncological patient, such as the presence of 
erythema and injuries, isolated or concomitant to 
complaints, such as: pain and difficulty of 
swallowing. 16 Thus, one can infer from the data 
that the more exposed the oral mucosa for 
antineoplastic agents and irradiation, the greater 
the degradation of its basal cells and, 
consequently, manifestation of the signs and 
symptoms typical of more severe mucositis grades 
will be more evident.  
Referring to Table 4, one can observe the 
incidence of oral mucositis associated, primarily, 
to platinum compounds, such as cisplatin; 
antimetabolites, such as cytarabine and 
methotrexate; alkaloids, such as vincristine 
sulfate and etoposide; and doxorubicin 
hydrochloride.  
When considering the chemotherapic 
treatment in an isolated way, the frequency of 
mucositis incidence is 40%, being that this 
average is variable according to the type and 
dose of the used chemotherapic agent. The 
chemo-induced mucositis varies from 40 to 76% 
for patients treated with standard and high-dose 
chemotherapy, respectively. 17 The most 
frequently associated chemotherapic agents with 
the development of oral mucositis are alkylating, 
antimetabolites and anthracyclines.18 
 A similar study has listed the most 
triggering drugs for the occurrence of oral 
mucositis, namely: cytarabine, methotrexate, 
vincristine sulfate and, beyond these, fluorouracil 
and vinblastine. 19 Cisplatin was observed by 
inducing oral mucositis, especially, when 
combined with radiotherapy. 20 Another relevant 
study considers that high doses of etoposide 
cause the most severe mucositis forms. 21 While a 
research on the same theme mentions that oral 
injuries are more determined by methotrexate, 
due to its action mechanism, which affects the 
DNA synthesis and causes one of the most 
pronounced stomatotoxicity effects.22  
 According to the analysis of these works, 
one can observe a similarity of the outcomes 
relating to the drugs considered more starter 
factors of oral mucositis by scholars with the 
findings of this analysis. Nonetheless, regardless 
of the chosen antineoplastic, it is important to 
understand that all patients, who are exposed to 
isolated chemotherapy or not, are susceptible to 
reactions such as the oral mucositis. This occurs 
because the increased concentration of 
chemotherapic drugs in the spittle increases the 
mucosal toxicity, resulting in a decreased 
volume, changes in the oral microbiota and 
decreased levels of spitting immunoglobulin.23 
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 The formation of free radicals by 
antineoplastic chemotherapy, although 
undesirable, is necessary, since is part of the 
action mechanism of these drugs. Most antiblastic 
agents interfere with the syntheses of the 
Deoxyribonucleic Acid (DNA) and the Ribonucleic 
Acid (RNA), of proteins and of the proper 
functioning of pre-shaped molecules. This fact 
enables the release of several toxic substances to 
the body, which affect healthy cells of tissues of 
rapid cell proliferation, as the oral mucosa cells. 
The most frequent side effects are: 
myelosuppression (bone narrow depression), 
alopecia and gastrointestinal and oral disorders, 
such as mucositis.24 
 By understanding the stomatotoxicity 
pathophysiology and the most antineoplastic 
inducer agents of oral mucositis, the nursing 
professional can draw, prior to the treatment 
submission, a specific care plan to each client, in 
order to interrupt the course of the deleterious 
effects and promote the life quality of patients. 
To identify nursing diagnoses, such as risk of 
impaired oral mucosa integrity, starting 
interventions and assessing the outcome thereof 
allow us to reflect on the good quality of care 
and accreditation of services that deal with the 
oncological audience.25 
It should be denoted that a variety of used 
chemotherapic drugs was inversely proportional 
to the oral mucositis grade, since, in mucositis in 
the grades 1 and 2, one can observe the effect of 
12 different antineoplastic agents, in each one, 
while this number falls to 8 different 
chemotherapic drugs in the mucositis in grade 3 
and to 6 kinds of antineoplastic agents in the 
mucositis in grade 4. 
 This data is relevant to understand that 
oral mucositis acquires a greater grade of 
severity according to the dose volume and the 
chemotherapic drug type, and not through the 
variety of medications. The dose, chemotherapic 
drug type and administration time are predictive 
in the onset of oral mucositis and not the variety 
of medicinal drugs.19 
One can understand that mucositis is a 
limiting condition to the oncological treatment, 
since it is capable of interrupting its continuity. 
In addition, it can be inferred that the 
interference in the oncological therapy is 
proportional to the mucositis grade, since the 
higher the graduation, the higher the oral and 
systemic impairment of the patient, due to 
bleeding, pain and diet restriction, which 
promotes nutritional and immunological 
weakness. Moreover, it represents a risk factor 
for sepsis in neutropenic patients, by increasing 
four times the relative risk for such a clinical 
picture23-25, which can negatively influence in the 
remission and survival rates of patients. 26 Tasting 
changes, due to injuries in the taste buds by 
radiation and chemotherapic agents, influence 
the food intake and contribute to the worsening 
of the nutritional profile, usually, already harmed 
by the underlying disease.27 
It is noteworthy to note that mucositis 
provokes interference in the oncological 
treatment, as well as becomes impactful for 
health systems. Such a sickness is burdensome, 
because of the possibility of extension of the 
admission days, coupled with local and systemic 
infections, supportive drug costs, such as opioids, 
anti-inflammatory medications and consumable 
stuffs. 
The aggravating of this situation is the 
striking omission or lack of knowledge by nurses 
before this issue. Study about nursing 
professional practices in oral health of admitted 
children with cancer has pointed out to the 
absence of protocols with regard to oral hygiene 
and oral disease prevention arising from the 
oncological treatment. 28 Interventions are 
empirically prescribed without a solid foundation 
in scientific evidence, since a huge part of the 
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surveyed professionals in the study have 
demonstrated the lack of daily procedures 
regarding the oral health.   
These results lead us back to a fragmented 
nursing care, in which a physical examination, 
diagnoses and interventions in the oral cavity 
seem to be realized as a field that goes beyond 
the competency of the nursing professional, 
which contradicts the semiological bases that are 
formers of such professionals, which recommend 
that the oral cavity examination is a part of the 
general physical examination of any patients 
served by the nurse and, when examining head 
and neck, it should inspect the oral cavity and 
tongue of the client, in order to detect any 
disease type and bacterial outbreaks. All this 
background corroborates the Holistic Care Theory 
of Myra Estrin Levine (internationally known as 
Levine’s Conservation Theory), which gazes the 
patient as a dynamic and unique being in its 
completeness and wholeness and that nursing 
interventions should be centered in the 
adaptation and reaction of patients towards the 
injuries. The nursing professional, despite the 
emotional burden of the oncological patient 
itself, should exercise its resilience to provide an 
assistance strengthened by encouraging and 
emotional issues.31 
 
 
From the discussed data, it is undeniable 
the relevance of the oral mucositis condition as an 
impactful factor to the life quality of the 
oncological patient. Therefore, drawing actual 
outcomes and indicators, which guide the nursing 
professional practice before the mucositis cases 
and that expose the severity of the issue in 
question, is the first step to establish a service 
that incorporates the technical quality and, 
especially, the practice of a true nursing care, by 
making use of empathetic and humanistic traces, 
which instigate the sensitivity of the subjects 
involved in the care. To empower the nursing 
professional practice with works that draw the 
profile of diseases and the affected audience is a 
way to make the labor routine closer to the 
scientific world and give subsidies for the 
strengthening of the profession and for the 
improvement of the care quality, in which the 
patient is the most favored subject. 
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